Facebook
Twitter
LinkedIn
ForwardTenecteplase vs. Alteplase: Time to Make the Switch?
The presentation will begin with a discussion of the role of IV thrombolysis in acute ischemic stroke (AIS). Next, I will discuss the different properties of alteplase (the only FDA-approved thrombolyticor AIS) vs. tenecteplase (off-label for AIS). Then, I will discuss the data regarding the use of tenecteplase for AIS. This data will include the statements made by the 2019 AHA Guidelines for the Early Management of Patients With Acute Ischemic Stroke as well as phase 2 and phase 3 trials of tenecteplase for AIS. Trials included in the presentation will be the NOR-TEST 1 & 2 trials, EXTEND-IA TNK trial, ACT trial, and TRACE-2 trial.
This program is offered through a partnership with Baptist Health.
Target Audience
This knowledge-based course is intended for Pharmacists.
Learning Objectives
1. Discuss the role of IV thrombolysis in acute ischemic stroke.
2. Compare and contrast the properties of tenecteplase and alteplase.
3. Evaluate the data examining the use of tenecteplase in various acute ischemic stroke populations.
TNK vs TPA Time to Make the Switch Program Packet.pdf
A copy of the presentation slides are located within the course content. Once you have registered for the course, please navigate to the 'Take Course' tab and click the navy blue 'Take Course' button. Navigate to the 'Course Materials' section of the course using the left-hand menu and download a PDF version of the program presentation. Course Materials will be added to the course the week of the live event.
Dr. Brianna Gray grew up in Petal, MS. She graduated from Presbyterian Christian High School and began her undergraduate career at The University of Mississippi in Oxford, MS. She was part of the early-entry pharmacy program during her time as an undergraduate student and graduated with a Bachelor of Science in Pharmaceutical Sciences in 2019. Dr. Brianna Gray then transitioned into pharmacy school at the University of Mississippi where she graduated Magna Cum Laude with a Doctor of Pharmacy degree in 2022. Currently, she is in her PGY-1 pharmacy residency program at Baptist Medical Center South in Montgomery, Alabama. After the completion of the PGY-1 residency, she will be completing a PGY-2 pharmacy residency program in internal medicine at University Health System in San Antonio, TX.
Dr. Rachel Settle is a Clinical Pharmacist at Baptist Medical Center South. She completed her Doctor of Pharmacy at the Harrison School of Pharmacy in Auburn, Alabama, and graduated Summa Cum Laude. Dr. Settle currently works as a Pharmacy Resident Preceptor and a Pharmacy Student Preceptor.
Auburn University is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education; credits are recognized nationwide. The Universal Activity Number for this knowledge-based program is 0001-9999-23-024-L01-P and is intended for pharmacists.
Available Credit
- 0.50 ACPE PharmacyAuburn University is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education; credits are recognized nationwide.
Price
Please click ADD TO Cart. You will be directed to your shopping cart for check out or you can proceed to check out by clicking on the shopping cart icon at the top right of your screen.
If you have a COUPON CODE, it can be applied on the shopping cart page or the CHECKOUT page. Please click APPLY TO ORDER.
Proceed to CHECKOUT and fill in your information. Choose your payment method and REVIEW ORDER.
You will be directed to our payment system to complete your order. An order confirmation email will be sent to your email address on file.
Once your order is complete, you will now have access to the course materials. Return to the course page and click TAKE COURSE to proceed.